Generated by AI
Scienture Holdings, Inc. is a pharmaceutical holding company focused on developing, commercializing, and distributing specialty products that address unmet needs in patient care. Through its operating businesses, the company works in areas such as central nervous system and cardiovascular therapies, with an emphasis on novel formulations and delivery systems designed for practical use by physicians, caregivers, and patients. Its current portfolio includes specialty pharmaceutical products and product candidates aimed at improving treatment options in targeted therapeutic categories. Based in Commack, New York, Scienture Holdings serves the healthcare market by combining product development, commercialization, and distribution capabilities within a focused specialty pharmaceutical platform.
Website2420 Brunello Trace
Lutz, FL, 33558
United States
The latest articles about SCNX.
Detailed price information for Scienture Holdings Inc (SCNX-Q) from The Globe and Mail including charting and trades.
Summary of Oct 19's posts. Generated by AI.
Summary of Oct 2's posts. Generated by AI.
Scienture Holdings reports Q3 revenue of $1.22M, up 256% QoQ, driven by Arbli growth and the launch of Rezenopy.
Summary of Aug 12's posts. Generated by AI.
Summary of Oct 13's posts. Generated by AI.
Investors talking about SCNX also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.